Graham Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153K Sell
40,131
-26,934
-40% -$130K ﹤0.01% 1091
2026
Q1
$355K Buy
67,065
+43,627
+186% +$269K 0.01% 749
2025
Q4
$181K Buy
+23,438
New +$209K ﹤0.01% 1066
2025
Q3
Sell
-16,361
Closed -$67.9K 1678
2025
Q2
$67.9K Buy
+16,361
New +$102K ﹤0.01% 1234
2022
Q1
Sell
-1,865
Closed -$45K 1032
2021
Q4
$45K Buy
+1,865
New +$58.9K ﹤0.01% 524
2021
Q1
Sell
-155,557
Closed -$3.98M 166
2020
Q4
$3.98M Sell
155,557
-10,886
-7% -$219K 0.15% 86
2020
Q3
$2.42M Buy
166,443
+25,000
+18% +$414K 0.08% 70
2020
Q2
$2.92M Hold
141,443
0.14% 63
2020
Q1
$4.48M Buy
+141,443
New +$3.55M 0.32% 44

Other funds holding VSTM

Graham Capital Management's VSTM Position: Q2 2026 in Review

Graham Capital Management reduced its Verastem (VSTM) stake by 40% in Q2 2026, selling an estimated $130K and leaving 40,131 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Graham Capital Management first reported a position in VSTM in Q1 2020 and has held it in 9 quarters since. The position peaked at $4.48M in Q1 2020. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Graham Capital Management held 40,131 shares of Verastem worth $153K as of Q2 2026.
  • Graham Capital Management sold 26,934 Verastem shares in Q2 2026, an estimated $130K.
  • Verastem made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1091 holding.
  • Graham Capital Management first reported a position in Verastem in Q1 2020 and has held it in 9 quarters since.
  • Graham Capital Management's Verastem position peaked at $4.48M in Q1 2020.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.